- Home
- VTGN vs HERZ Comparison
VTGN vs HERZ Comparison
Compare VTGN & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.69
Company Overview
Basic Information| Metric | VTGN | HERZ |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 23.7M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | VTGN | HERZ |
|---|---|---|
| Price | $0.69 | $16.70 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $0.90 | N/A |
| AVG Volume (30 Days) | ★ 777.1K | 12.6K |
| Earning Date | 06-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ N/A |
| Revenue This Year | $124.49 | N/A |
| Revenue Next Year | $353.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $1.62 |
| 52 Week High | $5.14 | $19.30 |
Technical Indicators
Market Signals| Indicator | VTGN | HERZ |
|---|---|---|
| Relative Strength Index (RSI) | 63.74 | 41.56 |
| Support Level | $0.54 | $15.27 |
| Resistance Level | $0.77 | $17.42 |
| Average True Range (ATR) | 0.06 | 0.73 |
| MACD | 0.01 | -0.21 |
| Stochastic Oscillator | 82.30 | 20.52 |
Price Performance
Historical Comparison VTGN
HERZ
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
About HERZ Herzfeld Credit Income Fund Inc.
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.